史赛克完成对ZuriMED的收购，以增强其肩部产品线-动脉网

Stryker completes acquisition of ZuriMED to enhance its shoulder offering

GlobeNewswire 等信源发布 2026-10-26 12:00



可切换为仅中文







Portage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) --

密歇根州波特奇，2026年10月26日（环球社讯）--

Stryker has completed its acquisition of ZuriMED, adding the FiberLocker System to its Sports Medicine portfolio

史赛克已完成对ZuriMED的收购，将FiberLocker系统纳入其运动医学产品组合

The acquisition adds a commercialized rotator cuff augmentation technology to Stryker’s shoulder portfolio

此次收购为史赛克的肩部产品组合增添了一项已商业化的肩袖增强技术

The addition expands Stryker’s ability to support shoulder specialists across sports medicine and shoulder care

此次扩充增强了史赛克在运动医学和肩部护理领域支持肩部专科医生的能力。

Stryker (NYSE:SYK), a global leader in medical technologies, announced it has completed the acquisition of ZuriMED, a privately held company and developer of the FiberLocker

医疗技术全球领导者史赛克（纽约证券交易所代码：SYK）宣布已完成对ZuriMED的收购，ZuriMED是一家私营公司，也是FiberLocker的开发商。

System.

系统。

The FiberLocker System is a commercialized rotator cuff augmentation technology designed to increase the biomechanical strength of the repair. The differentiated technology addresses an important clinical need in rotator cuff repair and expands Stryker’s ability to support shoulder surgeons with innovative solutions across the shoulder continuum of care..

FiberLocker系统是一种已商业化的肩袖增强技术，旨在提高修复的生物力学强度。该差异化技术满足了肩袖修复中的重要临床需求，并增强了史赛克公司通过创新解决方案支持肩关节外科医生、覆盖肩关节全程诊疗的能力。

“ZuriMED brings specialized expertise and a differentiated technology that complements our growing shoulder care capabilities,” said Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker. “Together, we have an opportunity to advance the FiberLocker technology, expand access to innovative treatment options and deliver greater value for our customers and their patients.”.

“ZuriMED 带来了专业化的专业知识和差异化的技术，与我们不断增长的肩部护理能力相辅相成，”史赛克公司 MedSurg 和神经技术集团总裁 Andy Pierce 表示。“携手合作，我们有机会推进 FiberLocker 技术，扩大创新治疗方案的可及性，并为客户及其患者创造更大价值。”

About Stryker

关于史赛克

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.

史赛克是全球医疗技术领域的领导者，我们与客户携手，致力于改善医疗健康服务。我们在医疗外科、神经技术和骨科领域提供创新的产品与服务，助力提升患者疗效和医疗健康成果。我们与全球客户并肩合作，每年惠及超过1.5亿名患者。

More information is available at .

更多信息请访问。

www.stryker.com.

www.stryker.com

Contacts

联系人

For investor inquiries:

投资者咨询：

Nick Mead

尼克·米德

Vice President, Investor Relations